Recipient hepatectomy technique may affect oncological outcomes of liver transplantation for hepatocellular carcinoma.
Riccardo PravisaniMaria De MartinoFederico MocchegianiFabio MelandroDamiano PatronoAndrea LauterioFabrizio Di FrancescoMatteo RavaioliMarco Fabrizio ZambelliClaudio BosioDaniele DondossolaQuirino LaiMatteo ZanchettaJule DingfelderLuca TotiAlessandro IacominoSermed NicolaeDavide GhinolfiRenato RomagnoliLuciano De CarlisSalvatore GruttadauriaMatteo CesconMichele ColledanAmedeo CarraroLucio CaccamoDaniele NicoliniMassimo RossiSilvio NadalinGeorg GyoriGiuseppe TisoneGiovanni VennarecciAndreas Arendtsen RostvedPaolo De SimoneMiriam IsolaUmberto BaccaraniPublished in: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2024)
To date, caval sparing (CS) and total caval replacement (TCR) for recipient hepatectomy in liver transplantation (LT) have been compared only in terms of surgical morbidity. Nonetheless, the CS technique is inherently associated with an increased manipulation of the native liver and later exclusion of the venous outflow, which may increase the risk of intraoperative shedding of tumor cells when LT is performed for HCC. A multicenter, retrospective study was performed to assess the impact of recipient hepatectomy (CS vs. TCR) on the risk of posttransplant HCC recurrence among 16 European transplant centers that used either TCR or CS recipient hepatectomy as an elective protocol technique. Exclusion criteria comprised cases of non-center-protocol recipient hepatectomy technique, living-donor LT, HCC diagnosis suspected on preoperative imaging but not confirmed at the pathological examination of the explanted liver, HCC in close contact with the IVC, and previous liver resection for HCC. In 2420 patients, CS and TCR approaches were used in 1452 (60%) and 968 (40%) cases, respectively. Group adjustment with inverse probability weighting was performed for high-volume center, recipient age, alcohol abuse, viral hepatitis, Child-Pugh class C, Model for End-Stage Liver Disease score, cold ischemia time, clinical HCC stage within Milan criteria, pre-LT downstaging/bridging therapies, pre-LT alphafetoprotein serum levels, number and size of tumor nodules, microvascular invasion, and complete necrosis of all tumor nodules (matched cohort, TCR, n = 938; CS, n = 935). In a multivariate cause-specific hazard model, CS was associated with a higher risk of HCC recurrence (HR: 1.536, p = 0.007). In conclusion, TCR recipient hepatectomy, compared to the CS approach, may be associated with some protective effect against post-LT tumor recurrence.
Keyphrases
- regulatory t cells
- liver metastases
- inferior vena cava
- patients undergoing
- randomized controlled trial
- end stage renal disease
- chronic kidney disease
- ejection fraction
- sars cov
- prostate cancer
- newly diagnosed
- mental health
- high resolution
- prognostic factors
- clinical trial
- rectal cancer
- peritoneal dialysis
- skeletal muscle
- weight loss
- fluorescence imaging
- alcohol consumption
- water quality